Sean Dowdy

Trending/Sean Dowdy

Dr. Sean Dowdy

Mayo Clinic: Ovarian Cancer Subtypes May Predict Response to Bevacizumab

CHICAGO — Molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has…

Sign up